HOME >> BIOLOGY >> NEWS
First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely

The first rigorous study of the dietary supplement resveratrol found that oral dietary supplements of resveratrol are unlikely to have any effect on breast and prostate cancer.

Dr. Thomas Walle, Medical University of South Carolina, presented the results at Experimental Biology 2004, as part of the scientific sessions of the American Society of Pharmacology and Experimental Therapeutics.

Resveratrol, a plant antioxidant found in abundance in grapes, wine, and peanuts, is widely sold as a dietary supplement with claims of numerous beneficial health effects. These range from extending life spans to preventing heart disease and cancer. However, these positive health effects have mainly been shown in cultured cells, and it has been unclear if resveratrol can reach the circulating blood in sufficient amounts to have therapeutic effects.

In the study by Dr. Walle and research associate Kristina Walle, C-14-Tagged resveratrol was administered both by mouth and intravenously to healthy volunteers. The researchers found that resveratrol (25-mg doses) is very well absorbed after oral dosing with most of the dose appearing in the urine in the first 12 hours. However, the urine contained resveratrol only as sulfate and glucuronic acid conjugates, none as the free, presumably active, form.

Likewise, the only blood samples containing free resveratrol were those drawn within 30 minutes after the intravenous injection. No free resveratrol was present in blood samples drawn after oral doses.

Based on this study's findings, Dr. Walle ways it would seem highly unlikely that resveratrol per se can have any effect on cardiovascular disease or cancer of such organs as the breast or prostate gland when consumed in the diet or as a dietary supplement.

However, he adds, it is still possible that orally administered resveratrol can prevent cancers along the aerodigestive tract. It is also possible that a resveratrol sulfate conjugate detected
'"/>

Contact: Sarah Goodwin
eb4press@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
19-Apr-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/26/2019)... ... , ... The American Society of Gene & Cell Therapy ... Achievement Award, Outstanding New Investigator Awards, and the Sonia Skarlatos Public Service Award. ... Meeting . , Outstanding Achievement Award, Dr. John Rossi, Lidow Family Research Endowed ...
(Date:3/25/2019)... (PRWEB) , ... March 25, 2019 , ... ... Interspersed Short Palindromic Repeats) gene editing technology since it came into use by ... Berkeley Visiting Scientist Kiana Aran is the first to combine the power of ...
(Date:3/23/2019)... PASADENA, Calif. (PRWEB) , ... March 22, 2019 ... ... Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a ... the NGS market. The five-tube kit is comprised of preformatted master mixes for ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... 2019 , ... The AACR annual conference pulls together a diverse group of ... cancer research. The Visikol team will be at the show at booth #3252 and ... as their digital pathology services . “For AACR this year we are highlighting ...
(Date:3/19/2019)... ... 2019 , ... This free webinar will review strategies for data management in modular ... reduce study build times by up to 30 percent, reducing cost while increasing quality, achieving ... without the need to migrate data – reducing risk and impact on trial success, trial ...
(Date:3/15/2019)... ATLANTA (PRWEB) , ... March ... ... acquisition of 100% equity in American Process Inc. and affiliate companies including ... Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON NOVEMBER 27, ... partner, the Eye Machine Canada Inc., had been given approval to begin a ... Age-Related Macular Degeneration (AMD). , The previous month, the medical devices bureau of ...
Breaking Biology Technology:
Cached News: